跳至主要内容
临床试验/NL-OMON53405
NL-OMON53405招募中不适用

Acupuncture for Nasal Congestion in Allergic Rhinitis: An Open-Label, Randomized, Monocenter Trial (ANCAR Trial) - Acupuncture for Nasal Congestion in Allergic Rhinitis (ANCAR)

Mermaid Medicine®0 个研究点目标入组 62 人开始时间: 待定最近更新:

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
62

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • Diagnosed AR by a physician.
  • Have one of the AR types: seasonal (SAR) or perennial (PAR) or mixed (MAR)
  • allergic rhinitis.
  • VAS nasal congestion: from 3-10.
  • Age: from 18 years.
  • Signed Informed Consent.

排除标准

  • COVID-19.
  • Acute common cold.
  • Influenza.
  • Fever (38°C or higher).
  • Acute nasal trauma (such as a fracture and epistaxis).
  • Irreversible nasal blockages (such as septum deviation, concha bullosa,
  • polyps and cysts).
  • Nasal and sinus cancer.
  • Pregnancy or planning for pregnancy.
  • Consumed decongestions, antihistamines, antibiotics or corticosteroids within
  • 2 weeks before the RCT.
  • Received acupuncture, Chinese herbal medicine or another complementary
  • treatment within 2 weeks before the RCT.
  • Received immunotherapy within 2 weeks before the RCT.
  • Patients refusing or unable to sign Informed Consent.

研究者

发起方
Mermaid Medicine®

相似试验